Abstract:Monofunctional platinum complexes offer a promising alternative to cisplatin in cancer chemotherapy, showing a unique mechanism of action. Their ability to induce minor helix distortions effectively inhibits DNA transcription. In our study, we synthesized and characterized three monofunctional Pt(II) complexes with the general formula [Pt(en)(L)Cl]NO3, where en = ethylenediamine, and L = pyridine (py), 2-methylpyridine (2-mepy), and 2-phenylpyridine (2-phpy). The hydrolysis rates of [Pt(en)(py)Cl]NO3 (1) and [Pt(en)(2-mepy)Cl]NO3 (2) decrease with the bulkiness of the auxiliary ligand with k(1) = 2.28 ± 0.15 × 10−4 s−1 and k(2) = 8.69 ± 0.98 × 10−5 s−1 at 298 K. The complex [Pt(en)(2-phpy)Cl]Cl (3) demonstrated distinct behavior. Upon hydrolysis, an equilibrium (Keq = 0.385 mM) between the complexes [Pt(en)(2-phpy)Cl]+ and [Pt(en)(2-phpy-H+)]+ was observed with no evidence (NMR or HR-ESI-MS) for the presence of the aquated complex [Pt(en)(2-phpy)(H2O)]2+. Despite the kinetic similarities between phenanthriplatin and (2), complexes (1) and (2) exhibit minimal activity against A549 lung cancer cell line (IC50 > 100 μΜ), whereas complex (3) exhibits notable cytotoxicity (IC50 = 41.11 ± 2.1 μΜ). In examining the DNA binding of (1) and (2) to the DNA model guanosine (guo), we validated their binding through guoN7, which led to an increased population of the C3′-endo sugar conformation, as expected. However, we observed that the rapid transition 2E (C2′-endo) ↔ 3E (C3′-endo), in the case of [Pt(en)(py)(guo)](NO3)2 ([1-guo]), slows down in the case of [Pt(en)(2-mepy)(guo)](NO3)2 ([2-guo]), resulting in separate signals for the two conformers in the 1H NMR spectra. This phenomenon arises from the steric hindrance between the methyl group of pyridine and the sugar moiety of guanosine. Notably, this hindrance is absent in [2-(9-MeG)] (9-MeG = 9-methylguanine), probably due to the absence of a bulky sugar unit in 9-MeG. In the case of (3), where the bulkiness of the substitution on the pyridine is further increased by a phenyl group, we observed a notable proximity between 9-MeGH8 and the phenyl ring of 2-phpy. Considering that only (3) exhibited good cytotoxicity against the A549 cancer cell line, it is suggested that auxiliary ligands, L, with an extended aromatic system and proper orientation in complexes of the type cis-[Pt(en)(L)Cl]NO3, may enhance the cytotoxic activity of such complexes.

NMR Studies on Reactivity of Dinuclear Platinum(Ⅳ) Complex Towards Guanosine-5'-Monophosphate and Glutathione

A Dinuclear Monofunctional Platinum(ii) Complex with an Aromatic Linker Shows Low Reactivity Towards Glutathione but High DNA Binding Ability and Antitumor Activity

Reactions of Platinum II Complexes with Sulfur- and Nitrogen-Containing Biomolecules: Selective Intermolecular Migration of the Thioether-Bound Platinum II Complex to the N7 Nitrogen Atom of Guanosine-5’-Monophosphate

Stabilization of Monofunctional Platinum–nucleotide Adducts: Reactions of N-acetyl-L-methionine Complexes with Guanosine 5′-Monophosphate and Guanylyl(3′–5′)guanosine

Kinetic Control of Reactions of a Sterically Hindered Platinum Picoline Anticancer Complex with Guanosine 5′-Monophosphate and Glutathione

Synthesis and Biological Activity of Binuclear Platinum Complexes Containing Two Monofunctional Cis-[Pt(Nh3)(2)Cl](+) Units Bridged by 4,4 '-Dipyridyl Selenides or Sulfides

Study on Three Single-Function of Three Nuclear Nitrogen Chelating Platinum(ii) Complex DNA Conjugates and Its Anti-Tumor Activity

[1H,15N] Nuclear magnetic resonance studies of [Pt(dien)Cl]+ (dien = diethylenetriamine): hydrolysis and reactions with nucleotides ‡

Synthesis, Characterization and DNA Binding Properties of Monofunctional Antitumor Pt(II) Complexes

Cytotoxic properties of platinum(IV) and dinuclear platinum(II) complexes and their ligand substitution reactions with guanosine-5′-monophosphate

In Vitro Anticancer Activity of Nanoformulated Mono- and Di-nuclear Pt Compounds

Tuning Anticancer Properties and DNA-binding of Pt(ii) Complexes Via Alteration of Nitrogen Softness/basicity of Tridentate Ligands.

Recognition of Platinum(ii) Amine Complexes by Nucleotides: Role Ofphosphate and Carbonyl Groups in ([15N3]diethylenetriamine)-(Guanosine 5′-Monophosphate)platinum(ii)

Effect of geometric isomerism on the anticancer property of new platinum complexes with glycine derivatives as asymmetric N, O donate ligands against human cancer

Kinetics and mechanism of the substitution reactions of [PtCl(bpma)]+, [PtCl(gly-met-S,N,N)] and their aqua analogues with l-methionine, glutathione and 5′-GMP

The Influence of the Auxiliary Ligand in Monofunctional Pt(II) Anticancer Complexes on the DNA Backbone

Unique Dna Binding Mode Of Antitumor Trinuclear Tridentate Platinum(Ii) Compound

Synthesis and Photoactivity of a Pt(II) Complex Based on an O-Nitrobenzyl-derived Ligand

Dna Cross-Linking Patterns Induced by an Antitumor-Active Trinuclear Platinum Complex and Comparison with Its Dinuclear Analogue

19F NMR Allows the Investigation of the Fate of Platinum(IV) Prodrugs in Physiological Conditions

Metal complexes as photochemical nitric oxide precursors : Potential applications in the treatment of tumors